Skip to main content
Premium Trial:

Request an Annual Quote

Grail, Veterans Affairs to Evaluate Galleri Cancer Early Detection Test

NEW YORK – Grail on Tuesday announced that it has entered a collaboration with the US Department of Veterans Affairs (VA) Veterans Health Administration and the Veterans Health Foundation to evaluate the real-world performance of the Galleri multi-cancer early detection blood test.

The company will provide Galleri to 10,000 veterans across approximately 10 participating sites, beginning with the VA Pittsburgh Healthcare System, over the next three years. Participating veterans will be eligible to enroll in REFLECTION, Grail's observational, multi-center study to evaluate the test's performance when combined with recommended cancer screenings in clinical settings. The study ultimately seeks 35,000 healthy volunteers.

"Cancer is a significant issue for US veterans, many of whom are at high risk," Charles Atwood, the study's lead researcher at VA Pittsburgh, said in a statement. "Grail’s multi-cancer early detection test will be provided to veterans, in addition to current recommended screenings, with the aim of improving early diagnoses and outcomes."

In a clinical study, Galleri showed the potential to detect more than 50 types of cancer, with a false positive rate of under 1 percent. The assay can determine a cancer's origin in a large proportion of cases.

Grail launched Galleri last year and is fielding it in several pilot programs, including one with Salt Lake City-based Intermountain Healthcare and another with Point32Health, among others.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.